Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov;7(11):5604-5610.
doi: 10.1002/cam4.1779. Epub 2018 Oct 10.

Strong impact of sulfotransferases on DNA adduct formation by 4-aminobiphenyl in bladder and liver in mice

Affiliations

Strong impact of sulfotransferases on DNA adduct formation by 4-aminobiphenyl in bladder and liver in mice

Yun Li et al. Cancer Med. 2018 Nov.

Abstract

Bladder cancer risk is 3-4 times higher in men than women, but the reason is poorly understood. In mice, male bladder is also more susceptible than female bladder to 4-aminobiphenyl (ABP), a major human bladder carcinogen; however, female liver is more susceptible than male liver to ABP. We investigated the role of sulfotransferase (Sult) in gender-related bladder and liver susceptibility to ABP. Sulfation reactions of aromatic amine bladder carcinogens catalyzed by Sult may generate highly unstable and toxic metabolites. Therefore, liver Sult may decrease bladder exposure to carcinogens by promoting their toxic reactions in the liver. Notably, the expression of several liver Sults is suppressed by androgen in male mice. Here, we show that two Sults are critical for gender-related bladder susceptibility to ABP in mice. We measured tissue level of N-(deoxyguanosin-8-yl)-4-aminobiphenyl (dG-C8-ABP), a principal ABP-DNA adduct, as readout of tissue susceptibility to ABP. We identified Sutl1a1 and to a lesser extent Sult1d1 as Sults that promote dG-C8-ABP formation in hepatic cells. In mice, gender gap in bladder susceptibility to ABP was narrowed by knocking out Sult1a1 and was almost totally eliminated by knocking out both Sutl1a1 and Sult1d1. This was accompanied by dramatic decrease in ABP genotoxicity in the liver (>97%). These results show the strong impact of the Sults on bladder and liver susceptibility to a human carcinogen. Because liver expression of both Sult1a1 and Sutl1d1 is suppressed by androgen in male mice, our results suggest that androgen renders bladder more exposed to ABP in male mice by suppressing Sult-mediated ABP metabolism in liver, which increases bladder delivery of carcinogenic metabolites.

Keywords: 4-Aminobiphenyl; bladder cancer; gender-related risk of bladder cancer; sulfotransferase; tobacco carcinogen.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The expression of Sult isoforms, their catalytic activities toward N‐OH‐ABP, and their effects on DNA adduct formation in mouse hepatic cells exposed to N‐OH‐ABP. Hepa1c1c7 cells were transfected with a plasmid expressing a specific Sult isoform or EV; 24 h later, the cells were either harvested for measurement of expression of each Sult isoform by Western blotting (A) and Sult enzymatic activity using N‐OH‐ABP as the substrate (B) or treated with N‐OH‐ABP at 30 μmol/L for 3 h, followed by measurement of dG‐C8‐ABP by LC/MS/MS (C). Each value in B and C is a mean ± SEM (n = 3)
Figure 2
Figure 2
dG‐C8‐ABP formation in the bladders and livers of WT mice, mice with Sult1a1 KO, or mice with KO of both Sult1a1 and Sult1d1. (A, C, E) Mice (8‐9 wk of age) were given a single dose of ABP (20 mg/kg, i.p.); 24 h later, the bladders and livers were collected for measurement of dG‐C8‐ABP level by LC/MS/MS. (B, D, F) Mice (8‐9 wk of age) were given ABP (2 mg/kg, i.p.) once daily for 7 d; 24 h after the final dose, the bladders and livers were collected for measurement of dG‐C8‐ABP level by LC/MS/MS. Each value is a mean ± SEM (n = 3‐9)

Similar articles

Cited by

References

    1. Cook MB, Dawsey SM, Freedman ND, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009;18:1174‐1182. - PMC - PubMed
    1. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306:737‐745. - PMC - PubMed
    1. Hartge P, Harvey EB, Linehan WM, et al. Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst. 1990;82:1636‐1640. - PubMed
    1. Riedel K, Scherer G, Engl J, Hagedorn HW, Tricker AR. Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. J Anal Toxicol. 2006;30:187‐195. - PubMed
    1. Skipper PL, Tannenbaum SR, Ross RK, Yu MC. Nonsmoking‐related arylamine exposure and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2003;12:503‐507. - PubMed

Publication types

Associated data